Currently submitted to: Transfer Hub (manuscript eXchange)
Date Submitted: Feb 8, 2026
Open Peer Review Period: Feb 10, 2026 - Apr 7, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Association between Maternal ABO Blood Group and Preeclampsia: Protocol for an Updated Systematic Review and Meta-analysis
ABSTRACT
Background:
Preeclampsia is a leading cause of maternal and perinatal morbidity and mortality worldwide. ABO blood group phenotypes have been associated with thrombosis, endothelial dysfunction, and inflammation, which are key mechanisms implicated in preeclampsia pathogenesis. Observational studies have reported inconsistent associations between maternal ABO blood group and preeclampsia, and several new studies have been published since the last comprehensive meta-analysis in 2021.
Objective:
An updated systematic review and meta-analysis is warranted to provide robust evidence on this association.
Methods:
This protocol follows the PRISMA-P 2015 guidelines and has been prospectively registered in the Open Science Framework (OSF) under the identifier 10.17605/OSF.IO/E3KTG (https://osf.io/zm4nf). Observational studies (case-control, cohort, and cross-sectional) reporting maternal ABO blood group and preeclampsia outcomes will be included. A systematic search will be conducted in PubMed/Medline, Embase, Scopus, Web of Science, and the Cochrane Library for studies published from January 2000 to October 31, 2025. Grey literature sources including Google Scholar, ProQuest Dissertations, and conference abstracts will also be searched. Two independent reviewers will perform study selection, data extraction, and risk of bias assessment using the Newcastle-Ottawa Scale. A random-effects meta-analysis will be performed to pool odds ratios for each blood group, and heterogeneity will be assessed using Cochran’s Q and I² statistics. Subgroup and sensitivity analyses will be conducted, and publication bias will be evaluated using funnel plots, Egger’s test, and trim-and-fill method. The certainty of evidence will be assessed using the GRADE approach.
Conclusions:
This review will provide updated evidence on whether maternal ABO blood group is associated with preeclampsia risk. The findings may help determine whether ABO blood group could serve as a risk marker for preeclampsia and inform future research and clinical practice. Clinical Trial: OSF 10.17605/OSF.IO/E3KTG
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.